MenoCheck picoAMH ELISA by Ansh Labs
Manufacturer Ansh Labs | Model: AL-124 | Available Worldwide
The MenoCheck® picoAMH ELISA is FDA cleared for in vitro diagnostic use as an aid in the determination of menopausal status in women between 42 and 62 years of age. This is the only AMH test with the sensitivity to quantify declining AMH concentrations in women who are entering their menopausal transition.
picoAMH ELISA
Average Rating: 4.5
2 Scientists have reviewed this product
Status:
Reviewer
Member since: 2019
Organization: Yeshiva University
-
- Ease of use
- After sales service
- Value for money
Great kit.
Rating: 5.0
Application Area: Translational research
"Very effective in detection at picogram level. Excellent."
Review date: 01 Aug 2019 | MenoCheck picoAMH ELISA
Status:
Reviewer Member since: 2019
Organization: Comilla Medical College Hospital
-
- Ease of use
- After sales service
- Value for money
Nice kit.
Rating: 4.0
Review date: 26 Jun 2019 | MenoCheck picoAMH ELISA
Application Area:Testing menupause
"It was easy to use. Price was reasonable."
Review date: 26 Jun 2019 | MenoCheck picoAMH ELISA
The Ansh Labs' MenoCheck picoAMH ELISA is a quantitative three-step sandwich immunoassay and is perfectly suited to the measurement of declining levels of AMH. The Ab pair was developed against specific linear epitopes on the associated dimers of AMH thus ensuring specificity and consistency of AMH detection, no detectable cross-reactivity to other isoforms of AMH, different conformations of AMH, or other TGF-Beta superfamily hormones.
- Calibrators are rHum AMH
- xhibits no interference by complement or heterophilic antibodies.
- Analytical measurable range of 7.6 – 1,091 pg/mL.
- Limit of quantitation is 3.2 pg/mL.
- Total 4.5 hour incubation at room temperature.
